Regulations

FDA Issues Warning Letter to Foshan Miwei Cosmetics

Trust MD SPF 30 stem cell face cream and inBlair Elevate SPF 15 moisturizer are cited for violations of CGMP regulations.

Foshan Miwei Cosmetics Co., Ltd.—a company that focuses on the manufacturing and trade of organic and natural skin care products that are often sold on Amazon—received a warning letter from the United States Food and Drug Administration (FDA) for violations of Current Good Manufacturing Practice (CGMP) regulations for finished pharmaceuticals. The FDA inspected the drug manufacturing facility in China from Oct. 20-24, 2025. FDA Letter Highlights According to the FDA letter: “This warnin...

Continue reading this story and get 24/7 access to Happi for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Happi Newsletters